Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management

References

• VlassaraHPalaceMRDiabetes and advanced glycation endproductsJ Intern Med2002251287 10111905595
   PubMed Web of Science ®Google Scholar
• CeramiCFoundsHNichollITobacco smoke is a source of toxic reactive glycation productsProc Natl Acad Sci U S A1997942513915 139209391127
   PubMed Web of Science ®Google Scholar
• GoldbergTCaiWPeppaMAdvanced glycoxidation end products in commonly consumed foodsJ Am Diet Assoc200410481287 129115281050
   PubMedGoogle Scholar
• VlassaraHUribarriJCaiWStrikerGAdvanced glycation end product homeostasis: exogenous oxidants and innate defensesAnn N Y Acad Sci2008112646 5218448795
   PubMed Web of Science ®Google Scholar
• VlassaraHStrikerGEAdvanced glycation endproducts in diabetes and diabetic complicationsEndocrinol Metab Clin North Am2013424697 71924286947
   PubMed Web of Science ®Google Scholar
• AhmedNAdvanced glycation endproducts – role in pathology of diabetic complicationsDiabetes Res Clin Pract20056713 2115620429
   PubMed Web of Science ®Google Scholar
• WuCHHuangSMLinJAYenGCInhibition of advanced glycation endproduct formation by foodstuffsFood Funct201125224 23421779560
   PubMed Web of Science ®Google Scholar
• BierhausASternDMNawrothPPRAGE in inflammation: a new therapeutic target?Curr Opin Investig Drugs2006711985 991
   PubMed Web of Science ®Google Scholar
• YonekuraHYamamotoYSakuraiSWatanabeTYamamotoHRoles of the receptor for advanced glycation endproducts in diabetes-induced vascular injuryJ Pharmacol Sci2005973305 31115750291
   PubMed Web of Science ®Google Scholar
• GoldinABeckmanJASchmidtAMCreagerMAAdvanced glycation end products: sparking the development of diabetic vascular injuryCirculation20061146597 60516894049
   PubMed Web of Science ®Google Scholar
• SternDYanSDYanSFSchmidtAMReceptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settingsAdv Drug Deliv Rev200254121615 162512453678
   PubMed Web of Science ®Google Scholar
• KoschinskyTHeCJMitsuhashiTOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyProc Natl Acad Sci U S A199794126474 64799177242
   PubMed Web of Science ®Google Scholar
• VlassaraHCaiWCrandallJInflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathyProc Natl Acad Sci U S A2002992415596 1560112429856
   PubMed Web of Science ®Google Scholar
• UribarriJPeppaMCaiWDietary glycotoxins correlate with circulating advanced glycation end product levels in renal failure patientsAm J Kidney Dis2003423532 53812955681
   PubMed Web of Science ®Google Scholar
• UribarriJPeppaMCaiWRestriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patientsJ Am Soc Nephrol2003143728 73112595509
   PubMed Web of Science ®Google Scholar
• HenleTAGEs in foods: do they play a role in uremia?Kidney Int Suppl200384S145 S14712694332
   PubMed Web of Science ®Google Scholar
• ErbersdoblerHFFaistVMetabolic transit of Amadori productsNahrung2001453177 18111455784
   PubMedGoogle Scholar
• GugliucciABendayanMRenal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cellsDiabetologia1996392149 1608635666
   PubMed Web of Science ®Google Scholar
• MonnierVMSellDRNagarajRHMaillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremiaDiabetes199241Suppl 236 411526333
   PubMed Web of Science ®Google Scholar
• NiwaTKatsuzakiTMomoiTModification of beta 2 m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serumKidney Int1996493861 8678648931
   PubMed Web of Science ®Google Scholar
• BucalaRMakitaZVegaGModification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiencyProc Natl Acad Sci U S A199491209441 94457937786
   PubMed Web of Science ®Google Scholar
• JensenLJØstergaardJFlyvbjergAAGE-RAGE and AGE Cross-link interaction: important players in the pathogenesis of diabetic kidney diseaseHorm Metab Res200537Suppl 126 3415918107
   PubMed Web of Science ®Google Scholar
• SaitoATakedaTSatoKSignificance of proximal tubular metabolism of advanced glycation end products in kidney diseasesAnn N Y Acad Sci20051043637 64316037287
   PubMed Web of Science ®Google Scholar
• VlassaraHAdvanced glycation in health and disease: role of the modern environmentAnn N Y Acad Sci20051043452 46016037266
   PubMed Web of Science ®Google Scholar
• VlassaraHStrikerLJTeichbergSFuhHLiYMSteffesMAdvanced glycation end products induce glomerular sclerosis and albuminuria in normal ratsProc Natl Acad Sci U S A1994912411704 117087972128
   PubMed Web of Science ®Google Scholar
• SmedsrødBMelkkoJArakiNSanoHHoriuchiSAdvanced glycation end products are eliminated by scavenger-receptor mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsBiochem J19973222567 5739065778
   PubMed Web of Science ®Google Scholar
• MatsumotoKSanoHNagaiREndocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class ABiochem J20003521233 24011062078
   PubMed Web of Science ®Google Scholar
• HansenBSvistounovDOlsenRNagaiRHoriuchiSSmedsrødBAdvanced glycation end products impair the scavenger function of rat hepatic sinusoidal endothelial cellsDiabetologia200245101379 138812378378
   PubMed Web of Science ®Google Scholar
• SantosJCValentimIBde AraújoORAtaide TdaRGoulartMODevelopment of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end productsInt J Mol Sci2013141019846 1986624084729
   PubMed Web of Science ®Google Scholar
• GohSYCooperMEClinical review: The role of advanced glycation end products in progression and complications of diabetesJ Clin Endocrinol Metab20089341143 115218182449
   PubMed Web of Science ®Google Scholar
• SanduOSongKCaiWZhengFUribarriJVlassaraHInsulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intakeDiabetes20055482314 231916046296
   PubMed Web of Science ®Google Scholar
• CaiWRamdasMZhuLChenXStrikerGEVlassaraHOral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1Proc Natl Acad Sci U S A20121093915888 1589322908267
   PubMed Web of Science ®Google Scholar
• UribarriJCaiWRamdasMRestriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1Diabetes Care20113471610 161621709297
   PubMed Web of Science ®Google Scholar
• NegreanMStirbanAStratmannBEffects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitusAm J Clin Nutr20078551236 124317490958
   PubMed Web of Science ®Google Scholar
• StirbanANegreanMGöttingCDietary advanced glycation endproducts and oxidative stress: in vivo effects on endothelial function and adipokinesAnn N Y Acad Sci20081126276 27918448830
   PubMed Web of Science ®Google Scholar
• MiyataTKurokawaKvan Ypersele de StrihouCRelevance of oxidative and carbonyl stress to long-term uremic complicationsKidney Int Suppl200076S120 S12510936808
   PubMed Web of Science ®Google Scholar
• RajDSChoudhuryDWelbourneTCLeviMAdvanced glycation end products: a Nephrologist’s perspectiveAm J Kidney Dis2000353365 38010692262
   PubMed Web of Science ®Google Scholar
• BuschMFrankeSMüllerAPotential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive proteinKidney Int2004661338 34715200442
   PubMed Web of Science ®Google Scholar
• TanALForbesJMCooperMEAGE, RAGE, and ROS in diabetic nephropathySemin Nephrol2007272130 14317418682
   PubMed Web of Science ®Google Scholar
• ChungACZhangHKongYZAdvanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signalingJ Am Soc Nephrol2010212249 26019959709
   PubMed Web of Science ®Google Scholar
• CoreshJAstorBCGreeneTEknoyanGLeveyASPrevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination SurveyAm J Kidney Dis20034111 1212500213
   PubMed Web of Science ®Google Scholar
• TanakaSAvigadGBrodskyBEikenberryEFGlycation induces expansion of the molecular packing of collagenJ Mol Biol19882032495 5053143838
   PubMed Web of Science ®Google Scholar
• HaitoglouCSTsilibaryECBrownleeMCharonisASAltered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagenJ Biol Chem19922671812404 124071618745
   PubMed Web of Science ®Google Scholar
• GuLHagiwaraSFanQRole of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytesNephrol Dial Transplant2006212299 31316263740
   PubMed Web of Science ®Google Scholar
• PalimeriSPaliouraEPiperiCAdditive effects of dietary glycotoxins and androgen excess on the kidney of a female rat modelAlex J Med Epub
   Google Scholar
• SebekováKKupcováVSchinzelRHeidlandAMarkedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantationJ Hepatol200236166 7111804666
   PubMed Web of Science ®Google Scholar
• YagmurETackeFWeissCElevation of Nepsilon-(carboxymethyl) lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosisClin Biochem200639139 4516321365
   PubMed Web of Science ®Google Scholar
• HyogoHYamagishiSIwamotoKElevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitisJ Gastroenterol Hepatol20072271112 111917559366
   PubMed Web of Science ®Google Scholar
• SatoTWuXShimogaitoNTakinoJYamagishiSTakeuchiMEffects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneysEur J Nutr20094816 1119083041
   PubMed Web of Science ®Google Scholar
• CaiWHeJCZhuLReduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expressionAm J Pathol200717061893 190217525257
   PubMed Web of Science ®Google Scholar
• PatelRBakerSSLiuWEffect of dietary advanced glycation end products on mouse liverPLoS One201274e3514322496902
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEPiperiCKalofoutisACreatsasGIncreased levels of serum advanced glycation end-products in women with polycystic ovary syndromeClin Endocrinol (Oxf)200562137 4315638868
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEPioukaALivadasSAnti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndromeEur J Endocrinol20091605847 85319208775
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEKatsikisIPiperiCIncreased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)Clin Endocrinol (Oxf)2008694634 64118363886
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEPiperiCPatsourisEImmunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovariesHistochem Cell Biol20071276581 58917205306
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEPiperiCKorkolopoulouPAccumulation of dietary glycotoxins in the reproductive system of normal female ratsJ Mol Med (Berl)200785121413 142017694292
   PubMed Web of Science ®Google Scholar
• KandarakiEChatzigeorgiouAPiperiCReduced ovarian glyoxalase-I activity by dietary glycotoxins and androgen excess: a causative link to polycystic ovarian syndromeMol Med2012181183 118922859292
   PubMed Web of Science ®Google Scholar
• TantalakiEPiperiCLivadasSImpact of dietary modification of advanced glycation end products (AGEs) on the hormonal and metabolic profile of women with polycystic ovary syndrome (PCOS)Hormones (Athens)201413165 7324722128
   PubMedGoogle Scholar
• ChatzigeorgiouAKandarakiEPiperiCDietary glycotoxins affect scavenger receptor expression and the hormonal profile of female ratsJ Endocrinol20132183331 33723823020
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEChatzigeorgiouAPapageorgiouEKoundourasDKoutsilierisMAdvanced glycation end-products and insulin signaling in granulosa cellsExp Biol Med Epub20155 7
   Web of Science ®Google Scholar
• BoutziosGLivadasSPiperiCPolycystic ovary syndrome offspring display increased oxidative stress markers comparable to gestational diabetes offspringFertil Steril2013993943 95023200689
   PubMed Web of Science ®Google Scholar
• SalahuddinPRabbaniGKhanRHThe role of advanced glycation end products in various types of neurodegenerative disease: a therapeutic approachCell Mol Biol Lett2014193407 43725141979
   PubMed Web of Science ®Google Scholar
• CaiWUribarriJZhuLOral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humansProc Natl Acad Sci U S A2014111134940 494524567379
   PubMed Web of Science ®Google Scholar
• KandarakisSAPiperiCTopouzisFPapavassiliouAGEmerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseasesProg Retin Eye Res20144285 10224905859
   PubMed Web of Science ®Google Scholar
• KandarakisSAPiperiCMoschonasDPKorkolopoulouPPapaloisAPapavassiliouAGDietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal ratsExp Eye Res20151371 1026026876
   PubMed Web of Science ®Google Scholar
• SharafHMatou-NasriSWangQAdvanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231Biochim Biophys Acta201518523429 44125514746
   PubMed Web of Science ®Google Scholar
• Rodriguez-TejaMGronauJHBreitCAGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survivalJ Pathol20152354581 59225408555
   PubMed Web of Science ®Google Scholar
• TakinoJYamagishiSTakeuchiMCancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-productsJ Oncol2010201073985220631911
   PubMedGoogle Scholar
• van HeijstJWNiessenHWHoekmanKSchalkwijkCGAdvanced glycation end products in human cancer tissues: detection of Nepsilon-(carboxymethyl)lysine and argpyrimidineAnn N Y Acad Sci20051043725 73316037299
   PubMed Web of Science ®Google Scholar
• FosterDSpruillLWalterKRAGE metabolites: a biomarker linked to cancer disparity?Cancer Epidemiol Biomarkers Prev201423102186 219125053712
   PubMed Web of Science ®Google Scholar
• JiaoLWeinsteinSJAlbanesDEvidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective studyCancer Res201171103582 358921540233
   PubMed Web of Science ®Google Scholar
• JiaoLTaylorPRWeinsteinSJAdvanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancerCancer Epidemiol Biomarkers Prev20112071430 143821527578
   PubMed Web of Science ®Google Scholar
• GroteVANietersAKaaksRThe associations of advanced glycation end products and its soluble receptor with pancreatic cancer risk: a case-control study within the prospective EPIC CohortCancer Epidemiol Biomarkers Prev2012214619 62822301828
   PubMed Web of Science ®Google Scholar
• TurnerDPAdvanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparityCancer Res201575101925 192925920350
   PubMed Web of Science ®Google Scholar
• HofmannSMDongHJLiZImproved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouseDiabetes20025172082 208912086936
   PubMed Web of Science ®Google Scholar
• ZhengFHeCCaiWHattoriMSteffesMVlassaraHPrevention of diabetic nephropathy in mice by a diet low in glycoxidation productsDiabetes Metab Res Rev2002183224 23712112941
   PubMed Web of Science ®Google Scholar
• VlassaraHStrikerGEAGE restriction in diabetes mellitus: a paradigm shiftNat Rev Endocrinol201179526 53921610689
   PubMed Web of Science ®Google Scholar
• PouillartPMauprivezHAit-AmeurLStrategy for the study of the health impact of dietary Maillard products in clinical studies: the example of the ICARE clinical study on healthy adultsAnn N Y Acad Sci20081126173 17618448812
   PubMed Web of Science ®Google Scholar
• VlassaraHCaiWGoodmanSProtection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1J Clin Endocrinol Metab200994114483 449119820033
   PubMed Web of Science ®Google Scholar
• Birlouez-AragonISaavedraGTessierFJA diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseasesAm J Clin Nutr20109151220 122620335546
   PubMed Web of Science ®Google Scholar
• KellowNJSavigeGSDietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic reviewEur J Clin Nutr2013673239 24823361161
   PubMed Web of Science ®Google Scholar
• BrownleeMVlassaraHKooneyAUlrichPCeramiAAminoguanidine prevents diabetes-induced arterial wall protein cross-linkingScience198623247581629 16323487117
   PubMed Web of Science ®Google Scholar
• HammesHPBrownleeMEdelsteinDSaleckMMartinSFederlinKAminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive ratDiabetologia199437132 358150227
   PubMed Web of Science ®Google Scholar
• Soulis-LiparotaTCooperMPapazoglouDClarkeBJerumsGRetardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic ratDiabetes199140101328 13341834497
   PubMed Web of Science ®Google Scholar
• NishizawaYWadaRBabaMTakeuchiMHanyu-ItabashiCYagihashiSNeuropathy induced by exogenously administered advanced glycation end-products in ratsJ Diabetes Investig201011–240 49
   Web of Science ®Google Scholar
• ForbesJMSoulisTThallasVRenoprotective effects of a novel inhibitor of advanced glycationDiabetologia2001441108 11411206401
   PubMed Web of Science ®Google Scholar
• Wilkinson-BerkaJLKellyDJKoernerSMALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 ratDiabetes200251113283 328912401720
   PubMed Web of Science ®Google Scholar
• ChengGWangLLLongLBeneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic ratsBr J Pharmacol200715281196 120617965740
   PubMed Web of Science ®Google Scholar
• OkamotoTYamagishiSInagakiYAngiogenesis induced by advanced glycation end products and its prevention by cerivastatinFASEB J200216141928 193012368225
   PubMed Web of Science ®Google Scholar
• StittAGardinerTAAldersonNLThe AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetesDiabetes20025192826 283212196477
   PubMed Web of Science ®Google Scholar
• DegenhardtTPAldersonNLArringtonDDPyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic ratKidney Int2002613939 95011849448
   PubMed Web of Science ®Google Scholar
• VasanSZhangXZhangXAn agent cleaving glucose-derived protein crosslinks in vitro and in vivoNature19963826588275 2788717046
   PubMed Web of Science ®Google Scholar
• CandidoRForbesJMThomasMCA breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changesCirc Res2003927785 79212623881
   PubMed Web of Science ®Google Scholar
• CoughlanMTForbesJMCooperMERole of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetesKidney Int Suppl2007106S54 S6017653212
   PubMed Web of Science ®Google Scholar
• KassDAShapiroEPKawaguchiMImproved arterial compliance by a novel advanced glycation end-product crosslink breakerCirculation2001104131464 147011571237
   PubMed Web of Science ®Google Scholar
• LittleWCZileMRKitzmanDWHundleyWGO’BrienTXDegroofRCThe effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failureJ Card Fail2005113191 19515812746
   PubMed Web of Science ®Google Scholar
• AldiniGVistoliGStefekMMolecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end productsFree Radic Res201347Suppl 193 13723560617
   PubMed Web of Science ®Google Scholar
• WinMTYamamotoYMunesueSRegulation of RAGE for attenuating progression of diabetic vascular complicationsExp Diabetes Res2012201289460522110482
   PubMedGoogle Scholar
• YamagishiSNakamuraKMatsuiTUedaSFukamiKOkudaSAgents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complicationsExpert Opin Investig Drugs2008177983 996
   PubMed Web of Science ®Google Scholar
• ParkLRamanKGLeeKJSuppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproductsNat Med1998491025 10319734395
   PubMed Web of Science ®Google Scholar
• BucciarelliLGWendtTQuWRAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null miceCirculation2002106222827 283512451010
   PubMed Web of Science ®Google Scholar
• BarileGRPachydakiSITariSRThe RAGE axis in early diabetic retinopathyInvest Ophthalmol Vis Sci20054682916 292416043866
   PubMed Web of Science ®Google Scholar
• KajiYUsuiTIshidaSInhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end productsInvest Ophthalmol Vis Sci2007482858 86517251488
   PubMed Web of Science ®Google Scholar
• LiFDrelVRSzabóCStevensMJObrosovaIGLow-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathyDiabetes20055451514 152215855340
   PubMed Web of Science ®Google Scholar
• PacherPLiaudetLSorianoFGMableyJGSzabóESzabóCThe role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetesDiabetes2002512514 52111812763
   PubMed Web of Science ®Google Scholar
• UedaSYamagishiSTakeuchiMOral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failureMol Med2006127–8180 18417088950
   PubMed Web of Science ®Google Scholar
• Diamanti-KandarakisEKatsikisIPiperiCAlexandrakiKPanidisDEffect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndromeClin Endocrinol (Oxf)2007661103 10917201808
   PubMed Web of Science ®Google Scholar
• PiperiCAdamopoulosCDalagiorgouGDiamanti-KandarakisEPapavassiliouAGCrosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseasesJ Clin Endocrinol Metab20129772231 224222508704
   PubMed Web of Science ®Google Scholar